文献速递流行病学与生物统计基础与转化研究

产前均衡能量蛋白补充对中低收入国家小脆弱新生儿类型影响的系统综述与个体参与者数据荟萃分析

The effect of prenatal balanced energy and protein supplementation on small vulnerable newborn types in low- and middle-income countries: A systematic review and meta-analysis of individual participant data.
PubMed 文献 · PLoS Med · 2026-02-17

本研究基于8项随机对照试验、共10252名参与者的个体数据,分析产前均衡能量蛋白(BEP)补充对小脆弱新生儿(SVN)类型的影响。结果显示BEP补充可降低早产-SGA-LBW、早产-AGA-LBW、足月-SGA-LBW等类型的风险,且在多产次、无贫血及孕20周前入组的女性中保护作用更强。

要点

  • 产前BEP补充使早产-SGA-LBW风险降低30%(RR 0.70)。
  • BEP补充使足月-SGA风险降低12%(RR 0.88)。
  • 孕20周前入组者中BEP对SVN类型的保护作用更强。

核心结论

  • 产前BEP补充可不同程度降低小脆弱新生儿类型的风险。

研究设计与样本

  • 系统综述与个体参与者数据荟萃分析,纳入8项中低收入国家产前BEP补充的随机对照试验,共10252名参与者(BEP组5164人,对照组5088人)。
  • 对照组包括因地制宜的标准照护、铁和叶酸补充剂或多种微量营养素补充剂。

主要发现

  • 在10组SVN分类中,BEP补充使早产-SGA-LBW风险降低30%(RR 0.70;95% CI [0.53, 0.91];P=0.009)。
  • BEP补充使早产-AGA-LBW风险降低25%(RR 0.75;95% CI [0.60, 0.93];P=0.009)。
  • BEP补充使足月-SGA-LBW风险降低20%(RR 0.80;95% CI [0.72, 0.90];P<0.001)。
  • 在4组分类中,BEP补充使早产-SGA风险降低31%(RR 0.69;95% CI [0.52, 0.91];P=0.008),使足月-SGA风险降低12%(RR 0.88;95% CI [0.81, 0.96];P=0.005)。
  • 在多产次和无贫血女性中,BEP对早产-SGA的保护作用更强;在孕20周前入组者中,BEP对4组分类下所有三种SVN类型的保护作用更强。

临床怎么用

  • 针对中低收入国家孕妇,产前BEP补充可作为降低早产-SGA等小脆弱新生儿风险的干预措施。
  • 对于多产次、无贫血及孕20周前入组的孕妇,BEP补充的保护作用可能更明显。

局限性

  • 部分BEP试验未被纳入。
  • 某些SVN类型的事件数较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Small vulnerable newborn (SVN) types, defined by combinations of being born too soon or too small, have distinct determinants, health consequences, and prevention strategies. The effects of prenatal balanced energy and protein (BEP) supplementation on SVN types remain unknown. METHODS AND FINDINGS: We conducted a systematic review and meta-analysis of individual participant data from eight randomized controlled trials of prenatal BEP supplements (N = 10,252, with 5,164 in the BEP arm and 5,088 in the control arm) in low- and middle-income countries were used. The control arms varied across studies and included context-specific standards of care, iron and folic acid supplements, or multiple micronutrient supplements. Newborns were classified into 10 groups through the combinations of preterm birth, small for gestational age (SGA) birth, and low birthweight (LBW), such as term-appropriate-for-gestational-age (AGA)-nonLBW, preterm-SGA-LBW, preterm-large-for-gestational-age-LBW, term-SGA-LBW, preterm-AGA-nonLBW, and other permutations. Newborns were also analyzed using a four-group categorization that included term-nonSGA, preterm-nonSGA, term-SGA, and preterm-SGA. Log-binomial models were used to estimate study-specific risk ratios (RRs), which were pooled using meta-analyses. Subgroup analyses were conducted by maternal age, parity, gestational age at enrollment, early pregnancy body mass index, and maternal anemia status. In the 10-group categorization of SVNs, on average, prenatal BEP supplementation led to a 30% lower risk of preterm-SGA-LBW (RR: 0.70; 95% CI [0.53, 0.91]; P = 0.009), a 25% lower risk of preterm-AGA-LBW (RR: 0.75; 95% CI [0.60, 0.93]; P = 0.009), and a 20% lower risk of term-SGA-LBW (RR: 0.80; 95% CI [0.72, 0.90]; P < 0.001). In the four-group categorization, prenatal BEP supplementation led to a 31% lower risk of preterm-SGA (RR: 0.69; 95% CI [0.52, 0.91]; P = 0.008) and a 12% lower risk of term-SGA (RR: 0.88; 95% CI [0.81, 0.96]; P = 0.005). The protective effect of prenatal BEP supplementation on preterm-SGA was stronger among multiparous women and women without anemia. The protective effects on all three SVN types under the four-group categorization were stronger among women enrolled before 20 weeks of gestation. The main limitations of the study included the absence of some BEP trials and the small event numbers for some SVN types. CONCLUSIONS: Prenatal BEP supplementation reduces the risk of SVNs to varying extents. Further research is needed to determine the optimal targeting approach for providing BEP supplements to vulnerable pregnant women who are most likely to benefit from the supplementation.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Wang D, Partap U, Liu E, et al. The effect of prenatal balanced energy and protein supplementation on small vulnerable newborn types in low- and middle-income countries: A systematic review and meta-analysis of individual participant data. PLoS Med. 2026. PMID: 41701774. doi:10.1371/journal.pmed.1004716

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。